Get Going After concussioN 2.0 (GAIN2)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04798885 |
|
Recruitment Status :
Recruiting
First Posted : March 15, 2021
Last Update Posted : October 6, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Commotio Cerebri Mild Traumatic Brain Injury | Behavioral: GAIN 2.0 | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 180 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Interdisciplinary Intervention for Patients With Post-concussion Symptoms 3-6 Months Post-injury (GAIN 2.0). A Stepped Wedge Cluster Randomised Trial: Effect on Symptoms, Participation in Daily Activities, and Labour Market Attachment |
| Actual Study Start Date : | May 12, 2021 |
| Estimated Primary Completion Date : | February 2023 |
| Estimated Study Completion Date : | March 2023 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Enhanced usual care
Participants will be informed about typical Post Concussion Symptoms and the process of typical recovery as well as given reassurance concerning the prognosis. Advice concerning the use of pain relief medication will also be provided.
|
|
|
Experimental: GAIN 2.0 intervention
An eight-week, interdisciplinary intervention program based on principles from cognitive behavioural therapy (CBT) and gradual return to activities.
|
Behavioral: GAIN 2.0
1) three structured group sessions of two hours duration performed jointly by a neuropsychologist, an occupational therapist and a physiotherapist. Relatives are also invited. 2) Up to five weekly semi-structured individual sessions of 30 min. duration with an allocated therapist |
- Change of at least seven in the sum score on the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) [ Time Frame: Three months after end of treatment ]RPQ is a self-report scale to measure the severity of Post Concussion Symptoms covering physical, cognitive, and emotional symptoms with 16 sub-items and a total sum score (range 0-64, higher score define more severe status)
- Sumscore in the dimension 'time spend on daily activities' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P). [ Time Frame: Three months after end of treatment ]Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions. The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.
- Sumscore in the dimension 'limitations' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P) [ Time Frame: Three months after end of treatment ]Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.
- Sumscore in the dimension 'satisfaction with participation' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P) [ Time Frame: Three months after end of treatment ]Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.
- Long term sick leave defined as public assistance benefits related to illness in more than three consecutive weeks [ Time Frame: Within 12 months after concussion ]Calculated based on weekly public assistance benefits extracted from the DREAM register
- Cumulated incidence proportion of participants on long term sick leave defined as receiving public assistance benefits related to illness in more than three consecutive weeks [ Time Frame: Within 36 months after concussion ]Calculated based on weekly public assistance benefits extracted from the DREAM register
- Proportion of employed participants defined as receiving no public assistance benefits except from state education fund grants [ Time Frame: At 12 months after concussion ]Calculated based on weekly public assistance benefits extracted from the DREAM register
- Proportion of employed participants defined as receiving no public assistance benefits except from state education fund grants [ Time Frame: At 36 months after concussion ]Calculated based on weekly public assistance benefits extracted from the DREAM register
- Degree of job stability based on whether labor market contributions have been paid [ Time Frame: At 12 months after concussion ]Monthly measure extracted from the DREAM register
- Degree of job stability based on whether labor market contributions have been paid [ Time Frame: At 36 months after concussion ]Monthly measure extracted from the DREAM register
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Concussion caused by a head trauma according to the diagnostic criteria recommended by WHO. Participants must be referred to the project within two to four months of injury.
- Age 18 to 60 years at the time of the trauma
- A RPQ score ≥20.
- Able to understand, speak and read Danish.
- Living in Central Denmark Region.
Exclusion Criteria:
- Objective neurological findings and/or acute trauma CT scan indicating neurological disease or brain damage.
- Previous concussion leading to persistent PCS within the last two years.
- Severe misuse of alcohol, prescription drugs and/or illegal drugs.
- Psychiatric morbidity or severe neurological disease that impedes participation in the program, i.e. Bipolar Disorder, autism, psychotic disorder (life time), multiple sclerosis etc.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04798885
| Contact: Jørgen F Nielsen, Professor | +45 7841 9043 | joerniel@rm.dk |
| Denmark | |
| Regionshospitalet Hammel Neurocenter | Recruiting |
| Hammel, Denmark, 8450 | |
| Contact: Jørgen Feldbæk Nielsen, Prof | |
| Principal Investigator: | Jørgen F Nielsen, Professor | Hammel Neurorehabilitation Centre and University clinic |
| Responsible Party: | University of Aarhus |
| ClinicalTrials.gov Identifier: | NCT04798885 |
| Other Study ID Numbers: |
GAIN 2.0 |
| First Posted: | March 15, 2021 Key Record Dates |
| Last Update Posted: | October 6, 2021 |
| Last Verified: | February 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Brain Injuries Brain Injuries, Traumatic Brain Concussion Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries Head Injuries, Closed Wounds, Nonpenetrating |

